Back to Search Start Over

Multiple myeloma and kidney disease

Authors :
Natalia Zarankiewicz
Katarzyna Kosz
Martyna Zielińska
Klaudia Remjasz
Aleksandra Kuchnicka
Julia Kuchnicka
Klaudia Sapuła
Jakub Aleksandrowicz
Wojciech Siedlecki
Source :
Journal of Education, Health and Sport, Vol 12, Iss 8 (2022)
Publication Year :
2022
Publisher :
Kazimierz Wielki University, 2022.

Abstract

Abstract Background: Multiple myeloma is a clonal plasma cell neoplasm which affects 1% of all malignancies. In this article we reviewed epidemiology, symptoms with particular attention to renal failure and its manifestation in multiple myeloma (MM). Material and methods: This paper was based on medical articles collected in PubMed from 2001 to 2022, medical websites and books. The research has been done by looking through key words such as: „multiple myeloma”, „myeloma cast nephropathy”, „bortezomib”, „RANKL” Results: Multiple myeloma has indolent course and many patients present renal disorders at the moment of diagnosis. The use of novel therapies can reverse renal failure. Conclusions: Treatment of the patients with MM and kidney disease is challenging for health care professionals. Doctors have to adjust treatment to provide the best therapeutic effects.

Details

Language :
English, Spanish; Castilian, Polish, Russian, Ukrainian
ISSN :
23918306
Volume :
12
Issue :
8
Database :
Directory of Open Access Journals
Journal :
Journal of Education, Health and Sport
Publication Type :
Academic Journal
Accession number :
edsdoj.85fa89f58ec448e9028d6f76990b653
Document Type :
article
Full Text :
https://doi.org/10.12775/JEHS.2022.12.08.089